Perfluoroaryl Radiolabeling for Biomolecule Integrity

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for radiolabeling biomolecules with 18F for PET imaging are limited by the need for expensive cyclotrons, harsh reaction conditions, and require advanced radiochemistry expertise, making the process costly and inefficient, with existing methods often damaging the biomolecules and requiring skilled chemists.

Innovation Solution

A chemical synthesis method that uses perfluoroaryl-conjugated target tracers, allowing for mild reaction conditions and 19F-to-18F substitution under ambient temperatures, enabling rapid and efficient radiolabeling with 18F salts, even by non-experts, using water-soluble perfluoroaryl compounds to maintain biological activity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If direct radiofluorination with 18F salts is performed under conventional conditions, then the radiolabeling can be achieved, but the harsh reaction conditions (high temperatures and harsh solvents) damage the biomolecule

Engineering Contradiction:
Improveradiolabeling efficiencyVSAvoidbiomolecule damage
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent introduces a perfluoroaryl intermediate compound that mediates the radiolabeling process. The biomolecule first conjugates with the cold perfluoroaryl group under mild conditions, then undergoes 18F/19F exchange. This intermediary approach allows the harsh 18F incorporation to occur on the stable perfluoroaryl group rather than directly on the biomolecule, protecting the biomolecule from damage while achieving efficient radiolabeling.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent performs the conjugation of the perfluoroaryl group to the biomolecule in advance, before the radiolabeling step. This preliminary action creates a stable intermediate that can withstand the subsequent harsh 18F incorporation conditions. By preparing the perfluoroaryl-conjugated biomolecule beforehand under mild conditions, the biomolecule is protected from direct exposure to damaging reagents and conditions.

Inventive Principle:
Principle #10Preliminary action

2Productivity

If conventional radiolabeling methods are used, then the 18F can be incorporated into the biomolecule, but the process requires expensive cyclotrons and advanced radiochemistry expertise

Engineering Contradiction:
Improveradiotracer productionVSAvoidequipment and expertise requirements
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The perfluoroaryl intermediate serves as a mediator that simplifies the radiolabeling process. Because the perfluoroaryl group has high affinity for 18F ions and undergoes efficient 18F/19F exchange under mild conditions, the process does not require complex cyclotron-based production methods. The intermediate acts as a bridge that enables radiolabeling with simpler, more accessible equipment and techniques.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes the chemical parameters of the radiolabeling process by using perfluoroaryl compounds with specific electronic and steric properties. These parameter changes enable the 18F incorporation to proceed under mild conditions (ambient temperature, aqueous buffers) rather than requiring the extreme conditions and specialized equipment traditionally needed for radiotracer production.

Inventive Principle:
Principle #35Parameter changes

3Loss of time

If the radiolabeling process is performed rapidly to maintain sufficient radioactivity, then the 18F remains active for imaging, but the harsh conditions required for rapid labeling damage the biomolecule

Engineering Contradiction:
Improveradioactivity decay lossVSAvoidbiomolecule integrity
Core Design Contradiction:
Loss of timeVSObject-affected harmful factors

Solution Approach 1:

The perfluoroaryl intermediate enables rapid radiolabeling under mild conditions by providing a highly reactive site for 18F incorporation. The 18F/19F exchange on the perfluoroaryl group proceeds quickly even at ambient temperature, achieving high radiolabeling efficiency without requiring harsh conditions that would damage the biomolecule. This resolves the contradiction between speed and gentleness in the radiolabeling process.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method allows for quick and efficient radiolabeling of biomolecules with 18F, preserving their biological activity and eliminating the need for expensive equipment or advanced expertise, ensuring sufficient radioactivity for imaging while maintaining the integrity of the biomolecules.

Implementation Method 1

reacting the 18F salt with the PFA-modified target tracer compound, thereby forming the 18F-labeled radiotracer

Methodology Applied
Scientific EffectNucleophilic aromatic substitution: Chemical Bonding

Data Source

PatentUS11628229B2Method of synthesizing <sup>18</sup>F radiolabeled biomolecular agents
Publication Date: 2023.04.18 THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIV OF ARIZONA
  • US11628229B2 patent drawing
  • US11628229B2 patent drawing
  • US11628229B2 patent drawing

AI summary

A method for preparing 18F radiolabeled biomolecules and agents for 18F-PET imaging is disclosed herein. A perfluoroaryl-conjugated target tracer is synthesized and purified with temperature and solvent conditions that are mild for the tracer molecule. The purified perfluoroaryl-conjugated target tracer is then labeled with 18F using 18F salts within a short reaction time, and with temperature and solvent conditions that are mild for the tracer molecule. The method provides a quick and convenient process that maintains the biological activities of the target molecules. The radio-labeled biomolecules may be used as contrast agents for Positron Emission Tomography (PET).